NCT05670366 (ENHANCED1) is a NA clinical trial of Activity tracker and chest strap in Type 1 Diabetes, sponsored by prof dr Pieter Gillard.

Who is sponsoring NCT05670366?

NCT05670366 is sponsored by prof dr Pieter Gillard.

What drugs are being tested in NCT05670366?

Interventions in NCT05670366: Activity tracker and chest strap, Diary app.

What condition does NCT05670366 study?

NCT05670366 studies Type 1 Diabetes.

Is NCT05670366 still recruiting?

NCT05670366 is currently completed. Last updated 17 March 2025.

Last reviewed 2025-03-17 · How we verify

NCT05670366: ENHANCED1

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Integration of Physical Activity Into the Clinical Decision Process of People with Type 1 Diabetes

Completed NA Last updated 17 March 2025

What this trial tests

NA trial testing Activity tracker and chest strap in Type 1 Diabetes in 33 participants. Completed in 31 July 2023.

Timeline

26 September 2022

Primary endpoint
31 July 2023

31 July 2023

Quick facts

Lead sponsor	prof dr Pieter Gillard
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	other
Enrollment	33
Start date	26 September 2022
Primary completion	31 July 2023
Estimated completion	31 July 2023
Sites	1 location across Belgium

Drugs / interventions tested

Activity tracker and chest strap
Diary app

Conditions studied

Type 1 Diabetes — all drugs for Type 1 Diabetes →

Sponsor

prof dr Pieter Gillard — full company profile →

Who can join

Adults 18 to 65, any sex, with Type 1 Diabetes. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Every person with type 1 diabetes needs personalized advice to integrate physical activity into daily diabetes management. The purpose of this study is to collect data on food intake, physical activity, glucose levels and insulin delivery from people with type 1 diabetes who are physically active. At least 25 people with type 1 diabetes will be asked to perform 25 sports activities of at least half an hour, wear an activity tracker (day and night) and chest strap (during sports activities), and log data on food intake, periods and type of physical activity, and feelings (e.g., sick, stress) in a diary app. Diabetes data such as insulin administration and sensor data will be collected through diabetes management platforms. The primary endpoint involves a database containing data on glucose, insulin administration, physical activity, and food intake of people with type 1 diabetes for statistical analyses and visualizations regarding the relationship between physical activity and blood glucose response.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Type 1 Diabetes

Currently open trials in the same condition.

NCT07061574 — A Randomized Phase 1/2 Trial of Low Dose Anti-thymocyte Globulin (ATG) With Subsequent Adalimumab or Verapamil in New On · Phase 1, PHASE2 · recruiting
NCT07360080 — Long-Term Outcomes of Teplizumab in Routine Clinical Care · recruiting
NCT07457580 — Real-World Study of Patients With Type 1 Diabetes Treated With Teplizumab as Part of Managed Access Programs (MAPs) · recruiting
NCT07212179 — Safety and Feasibility of a Self-Learning Bolus Calculator With Simplified Meal Announcement in Adolescents With Type 1 · NA · recruiting
NCT07287943 — To Study the Efficacy and Safety of Medtronic 780G Insulin Pump in People With Gastroparesis and Type 1 Diabetes. · NA · recruiting

Other prof dr Pieter Gillard trials

Trials by the same sponsor.

NCT05434559 — Evaluation of Glycemic Control in Adults With Type 1 Diabetes When Switching to Insulin Degludec · completed
NCT05109520 — Evaluation of Glycemic Control and Quality of Life in Adults With Type 1 Diabetes During Continuous Glucose Monitoring W · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05670366 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by prof dr Pieter Gillard
Last refreshed: 17 March 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05670366.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing